PD-1 and PD-L1 inhibitors are a class of drugs used for cancer treatment. These drugs help boost the immune system's ability to recognize and destroy tumor cells by blocking interaction between programmed cell death protein 1 (PD-1) and its ligand PD-L1. The need for cancer treatment has been rising significantly owing to increasing prevalence of various cancer types globally. PD-1 and PD-L1 inhibitors offer promising alternatives to conventional cancer treatment options by improving ... Read more

PD-1 and PD-L1 inhibitors are monoclonal antibodies used for cancer immunotherapy. They block inhibitory signals known as PD-1 and PD-L1, which helps T cells attack cancer cells. These drugs restore the ability of the immune system to recognize and destroy tumor cells. They are used for the treatment of various cancers like lung cancer, renal cancer, head and neck cancer, lymphoma and melanoma.